Therefore, we believe that the transcription of the MGMT promoter could be blocked by inhibiting the ERK pathway to reduce the level of MGMT protein, thus antagonising the drug resistance of tumour cells to TMZ. This evidence concerns the gene MGMT and neoplasm.